212 related articles for article (PubMed ID: 12131543)
41. Relationship between electrocardiographic voltage and geometric patterns of left ventricular hypertrophy in patients with essential hypertension.
Tomita S; Ueno H; Takata M; Yasumoto K; Tomoda F; Inoue H
Hypertens Res; 1998 Dec; 21(4):259-66. PubMed ID: 9877519
[TBL] [Abstract][Full Text] [Related]
42. Regression of left ventricular hypertrophy and systolic function in hypertensive patients during long-term treatment with ketanserin.
Coto V; Cocozza M; Oliviero U; Lucariello A; Picano T; Castaldo B; Iovino V; Cacciatore L
Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():77-80. PubMed ID: 2149516
[TBL] [Abstract][Full Text] [Related]
43. Negative U-wave as a predictor of antihypertensive treatment effect on regression of echocardiographic hypertrophy in hypertensive patients.
Kishida H; Saitoh T; Oikawa K; Honma H; Kusama Y
Jpn Heart J; 1999 Jan; 40(1):31-44. PubMed ID: 10370395
[TBL] [Abstract][Full Text] [Related]
44. Exercise-induced cardiac remodeling in non-elite endurance athletes: Comparison of 2-tiered and 4-tiered classification of left ventricular hypertrophy.
Trachsel LD; Ryffel CP; De Marchi S; Seiler C; Brugger N; Eser P; Wilhelm M
PLoS One; 2018; 13(2):e0193203. PubMed ID: 29462182
[TBL] [Abstract][Full Text] [Related]
45. Changes in cardiac diastolic dimensions precede hypertrophy in early stages of hypertension.
Lemme C; Lindvall K; de Faire U
J Hum Hypertens; 1998 Oct; 12(10):679-83. PubMed ID: 9819015
[TBL] [Abstract][Full Text] [Related]
46. Blood Pressure Lowering in Patients With Central Hypertension: A Randomized Clinical Trial.
Sharman JE; Otahal P; Stowasser M; Stanton T; Reid CM; Nolan M; Roberts-Thomson P; Negishi K; Greenough R; Stewart S; Marwick TH; Abhayaratna WP
Hypertension; 2024 Jun; 81(6):1400-1409. PubMed ID: 38563148
[TBL] [Abstract][Full Text] [Related]
47. Effects of angiotensin-converting enzyme inhibition on left ventricular geometric patterns in patients with essential hypertension.
De Castro S; Pelliccia F; Cartoni D; Funaro S; Melillo G; Beni S; Magni G; Migliau G; Fedele F
J Clin Pharmacol; 1996 Dec; 36(12):1141-8. PubMed ID: 9013371
[TBL] [Abstract][Full Text] [Related]
48. Relations of pulse pressure and other components of blood pressure to preclinical echocardiographic abnormalities.
Celentano A; Palmieri V; Di Palma Esposito N; Pietropaolo I; Arezzi E; Mureddu GF; de Simone G
J Hypertens; 2002 Mar; 20(3):531-7. PubMed ID: 11875322
[TBL] [Abstract][Full Text] [Related]
49. Effect of angiotensin type I-receptor blockade on left ventricular remodeling in pressure overload hypertrophy.
Kiatchoosakun S; Lawrence E; Nakada S; Restivo J; Walsh RA; Hoit BD
J Card Fail; 2001 Dec; 7(4):342-7. PubMed ID: 11782858
[TBL] [Abstract][Full Text] [Related]
50. The heart in the hypertensive elderly.
Grodzicki T; Messerli FH
J Hum Hypertens; 1998 Sep; 12(9):593-7. PubMed ID: 9783486
[TBL] [Abstract][Full Text] [Related]
51. Parallel increase in carotid, brachial and left ventricular cross-sectional areas in arterial hypertension.
Fantini F; Barletta G; Del Bene R; Lazzeri C; La Villa G; Franchi F
J Hum Hypertens; 1997 Aug; 11(8):515-21. PubMed ID: 9322833
[TBL] [Abstract][Full Text] [Related]
52. Centralized echocardiogram quality control in a multicenter study of regression of left ventricular hypertrophy in hypertension.
Gosse P; Guez D; Guéret P; Dubourg O; Beauchet A; de Cordoüe A; Barrandon S
J Hypertens; 1998 Apr; 16(4):531-5. PubMed ID: 9797199
[TBL] [Abstract][Full Text] [Related]
53. Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence.
Aune A; Ohldieck A; Halvorsen LV; Brobak KM; Olsen E; Rognstad S; Larstorp ACK; Søraas CL; Rossebø AB; Rösner A; Grytaas MA; Gerdts E
High Blood Press Cardiovasc Prev; 2024 Mar; 31(2):157-166. PubMed ID: 38530572
[TBL] [Abstract][Full Text] [Related]
54. Hypertension and alterations in left ventricular structure and geometry in African Americans: the Jackson Heart Study.
Abdalla M; Booth JN; Diaz KM; Sims M; Muntner P; Shimbo D
J Am Soc Hypertens; 2016 Jul; 10(7):550-558.e10. PubMed ID: 27339075
[TBL] [Abstract][Full Text] [Related]
55. Effects of the combinations of amlodipine/valsartan versus losartan/hydrochlorothiazide on left ventricular hypertrophy as determined with magnetic resonance imaging in patients with hypertension.
Bruder O; Jensen CJ; Bell M; Rummel R; Boehm G; Klebs S; Sieder C; Senges J
J Drug Assess; 2012; 1(1):1-10. PubMed ID: 27536421
[TBL] [Abstract][Full Text] [Related]
56. Adjustment of ECG left ventricular hypertrophy criteria for body mass index and age improves classification accuracy. The effects of hypertension and obesity.
Norman JE; Levy D
J Electrocardiol; 1996; 29 Suppl():241-7. PubMed ID: 9238407
[TBL] [Abstract][Full Text] [Related]
57. Left ventricular hypertrophy in mild essential hypertension. Its progression, prediction and treatment strategy.
Doba N; Tomiyama H; Yoshida H; Kihara Y; Watanabe G; Hinohara S
Jpn Heart J; 1996 Jul; 37(4):417-29. PubMed ID: 8890756
[TBL] [Abstract][Full Text] [Related]
58. Power spectral analysis of the heart rate in hypertensive patients with and without left ventricular hypertrophy: the effect of a left ventricular mass reduction.
Muiesan ML; Rizzoni D; Zulli R; Castellano M; Bettoni G; Porteri E; Agabiti-Rosei E
J Hypertens; 1998 Nov; 16(11):1641-50. PubMed ID: 9856365
[TBL] [Abstract][Full Text] [Related]
59. Losartan improves diastolic ventricular filling of hypertensive patients with diastolic dysfunction.
Ayoub JC; Vitola JV; Parro A; Costa OM; Delgado AS; de Parma AH; Takakura IT
Hypertens Res; 1999 Jul; 22(2):155-9. PubMed ID: 10487333
[TBL] [Abstract][Full Text] [Related]
60. Age-dependent implications of left ventricular hypertrophy regression in patients with hypertension.
Chu HW; Hwang IC; Kim HM; Park J; Choi H; Choi HM; Yoon YE; Cho GY
Hypertens Res; 2024 May; 47(5):1144-1156. PubMed ID: 38238511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
